Posters will be displayed Monday 2 December - Wednesday 4 December 2024.
This is a list of all poster presentations.
Please refer to the conference app for the poster displays per day, and poster numbers.
Polyphenols from Sorghum bicolor Suppress Tauopathies: Evidence from In Silico and In Vivo Studies (21160)
8:30 AM
Familiarity and time influence how the brain integrates sensory and emotional information. (21179)
8:30 AM
Seeking into the pathogenesis of Parkinson’s disease and the development of the therapeutics (21267)
8:30 AM
Cellular mechanisms of generation of synchronized rhythmic burst in the ventromedial hypothalamus. (21333)
8:30 AM
Intranasal antipsychotic administration: a viable route of administration to avoid debilitating peripherally-induced side-effects (21360)
8:30 AM
The role of MAST3 in neurodevelopment and disease (21372)
8:30 AM
The Enzyme-Responsive Delivery System for Reprogramming Reactive Glia into Neural Progenitors and Neurons after Brain Injury (21393)
8:30 AM
Design and Development of Choline Acetyltransferase Fluorescence Imaging Probes (21419)
8:30 AM
Evaluating mineralocorticoid receptor modulators and gene variants on microglial function (21424)
8:30 AM
Multi-scale imaging of the hypogastric nerves in the adult human (21435)
8:30 AM
Impact of third hand exposure to e-cigarettes on cognition and brain health (21436)
8:30 AM
Modulating Brain Network Connectivity with Transcranial Alternating Current Stimulation (21437)
8:30 AM
Cerebral blood flow alterations in brain regions associated with cardiovascular autonomic control following mild traumatic brain injury: an arterial spin labelling study (21439)
8:30 AM
Assessing the effect of repetitive TMS on people with multiple sclerosis (21443)
8:30 AM
Using Brain Microglia Autofluorescence as an Index of Neuroinflammation (21446)
8:30 AM
Treatments for those who have none platform: from Western Australia to nationwide (21465)
8:30 AM
Identifying Connectome-based Neuroimaging Biomarkers Associated with Behavioral Changes in An Animal Model of Depression: An Exploratory Analysis (21471)
8:30 AM
Turnover dynamics of CNS border-associated macrophages in adult mice (21473)
8:30 AM
Superior colliculus anatomy and neurochemistry remain intact following primary visual cortex lesion (21474)
8:30 AM
A genetic vaccination approach to generating cognition-enhancing antibodies in mice (21481)
8:30 AM
Title: Evaluation of anti-inflammatory molecule in restoring K+ homeostasis during neurodegeneration (21487)
8:30 AM
Targeted Delivery of the NgR-(1-310)ecto-Fc-Myc Protein Enhances Neurorepair during Experimental Autoimmune Encephalomyelitis (21489)
8:30 AM
Inflammatory responses and impaired BBB integrity are required for the neurobehavioral changes observed in Acute Rheumatic Fever (21492)
8:30 AM
Trajectories of Outcomes in Neurological Conditions (TONiC): Motor Neuron Disease & Parkinson’s disease (21499)
8:30 AM
Effect of extreme light/dark cycles on monoamine levels, physiological indices, and emotional behaviors in rats (21500)
8:30 AM
Plastic Perils: An In Vitro Study Investigating Microplastic Exposure in the Gut-Brain-Axis (21501)
8:30 AM
A novel perfusion circuit enabling long-term in-vitro electrophysiological analysis and neuromodulation. (21512)
8:30 AM
Characterising the role of the locus coeruleus norepinephrine system in the zebrafish model (21517)
8:30 AM
Combined administration of D-cycloserine (DCS) and MK-801 disrupts threat memory reconsolidation in mice and reduces pERK-expressing neurons in the lateral amygdala (21523)
8:30 AM
Distribution of vasoactive intestinal polypeptide (VIP)-expressing interneurons across the marmoset cortex (21524)
8:30 AM
Moderate coffee and tea consumption is associated with slower cognitive decline: data from UK Biobank (21525)
8:30 AM
Behavioural Effects of High Doses of Psilocybin in Female Rats (21528)
8:30 AM
A proteomics study of the prefrontal cortex following life-long exposure to environmental enrichment (21555)
8:30 AM
Characterizing Developmental Myelination and Auditory Processing in Zebrafish Larvae (21590)
8:30 AM
DASH and Cognitive Health in Older Adults: Findings from the WA Memory Study. (21598)
8:30 AM
As Time Ticks, Does Your Brain Pick Sides? Exploring Age-Related Shifts in Hemispheric Asymmetry (21610)
8:30 AM
Pericytes are prevalent at capillary loop structures in the Tasmanian Devil brain (21619)
8:30 AM
Investigating CNS white matter defects in a murine model of Aicardi-Goutières syndrome (21650)
8:30 AM
Exploratory research into the effects of exercise, rhythm, and music on Central Auditory Processing Disorder in children. (21658)
8:30 AM
More than making amyloid-β: Defining the roles for Presenilins in microglial function. (21753)
8:30 AM
Insights into neurological immune-related adverse events associated with immune checkpoint inhibitor cancer therapy (21764)
8:30 AM
The role of a cortico-hypothalamic pathway on hunger and metabolism (21768)
8:30 AM
A new angle on transcranial magnetic stimulation coil orientation: A targeted narrative review (21777)
8:30 AM
Pharmacological treatment of brain copper deficiency (21781)
8:30 AM
Retinol supplementation improves locomotion and reduces anxiety-like behavior in male mice fed a high-fat diet (21784)
8:30 AM
Brain computer interface for tetraplegic patients using EEG signals of motor imagery (21792)
8:30 AM
Do statins enhance cerebral collateral angiogenesis? (21795)
8:30 AM
Can marmosets maintain the balance between response execution and action inhibition? (21802)
8:30 AM
Whole genome pleiotropy between Alzheimer’s Disease and Autoimmune Disorders (21806)
8:30 AM
Impact of Neuropathic Pain on Fear Learning Systems Within the Brain (21821)
8:30 AM
Alterations in lipid droplet biology in Motor Neurone Disease (21839)
8:30 AM
Positive Contrast Magnetic Resonance Imaging of Iron Oxide Nanoparticles in Patient-Derived Orthotopic Glioblastoma (21849)
8:30 AM
Mechanisms underlying diet-induced analgesia in rodent models of chronic pain (21861)
8:30 AM
An innovative approach for conducting 3D electrophysiological recordings within intact organoids. (21880)
8:30 AM
An Innovative Therapy for Alzheimer’s Disease: Reducing DYRK1A Expression using Antisense Oligonucleotides (21885)
8:30 AM
Anti-Sez6 antibodies modulate Sez6 surface levels and protein turnover (21886)
8:30 AM
AUS-mTBI Extend: An extended and innovative model to predict recovery for people with mild traumatic brain injury. (21891)
8:30 AM
A Novel, Minimally Invasive Mode of Delivery for Red and Near-Infrared-Light Therapy of the Spinal Cord (21894)
8:30 AM
The effect of contralateral cortex injection of AAV1-CRMP2 on C6/7 hemi-contusion spinal cord injury repair in Fischer rats (21897)
8:30 AM
Amacrine cells in the ganglion cell layer of human and macaque monkey retina (21898)
8:30 AM
The Infectious Contribution to Alzheimer's disease -- assessing the role of Chlamydia pneumoniae infection (21899)
8:30 AM
Novel Methods to Achieve the Highest Resolution in-vivo Child Brain MRI — A Pilot Study (21902)
8:30 AM
Excessive repetitive behavior, enhanced spatial learning, altered dendritic features, and aberrant protein expression in Fbxo25 knockout mice (21905)
8:30 AM
Boosting Brainwaves: How Low-Intensity rTMS Modulates Synaptic Plasticity During Skilled Learning in Mice (21906)
8:30 AM
Oxygenating Hydrogels: A Therapeutic Approach for Brain Injury (21907)
8:30 AM
RNA editing of the GluA2 Q/R site regulates dendritic spines in hippocampal neurons (21908)
8:30 AM
Functional abilities are associated with Alzheimer disease-related fluid biomarkers: A systematic review. (21911)
8:30 AM
Incremental Value of Baseline Cognition, APOE ε4, and Amyloid-beta for Predicting Progression to Mild Cognitive Impairment in Cognitively Normal Older Adults (21917)
8:30 AM
Altered post stress coping and reward seeking behaviours in chronically stressed mice (21918)
8:30 AM
Role and therapeutic targeting of NFIX in the neurodevelopmental Malan syndrome (21919)
8:30 AM
Using the live rat stress paradigm to investigate approach-avoidance behaviour under threat (21927)
8:30 AM
Diphtheria toxin mediated microglia depletion in CD11b-DTR mice (21928)
8:30 AM
Dimension of visual information interacts with working memory in monkeys and humans (21931)
8:30 AM
A spatially resolved single-nucleus multi-omics approach to understand how stress contributes to psychiatric disorders (21933)
8:30 AM
Generation of induced pluripotent stem cells (iPSCs) from Monotremes (21934)
8:30 AM
Morphological and functional alterations of Müller cells during early Diabetic Retinopathy (21935)
8:30 AM
Anterograde trafficking of the BACE1 substrate Seizure-related Protein 6 in neurons (21938)
8:30 AM
Chemistry Matters: Targeted Therapies for Neurological Disorders. (21946)
8:30 AM
Seizure-responsive hydrogel programmed to modulate ion channels involved in epileptic seizure (21948)
8:30 AM
Tissue concentrations of a highly bioavailable phytosomal curcumin formulation and their correlation with glial inflammatory markers in the GFAP- IL6 mouse model of chronic neuroinflammation (21950)
8:30 AM
Small Molecule Base Exchange Inhibitor of TIR:TIR Domain Formation and Activation in Human SARM1 (21951)
8:30 AM
Freezing and Analgesic Learned Fear Behaviours in a Mouse Neuropathic Pain Model (21955)
8:30 AM
Distinct Neural Activity Patterns across Fear-Related Learning Paradigms using Engram Tagging (21958)
8:30 AM
A Multi-Omic Approach for the Detection of Melanoma Brain Metastasis (21963)
8:30 AM
Morphometric brain changes in an ovine CLN6 neuronal ceroid lipofuscinosis model (21968)
8:30 AM
SOX transcription factors as LINE-1 retrotransposon modulators in the human brain (21970)
8:30 AM
LncRNA regulation of lysosome function in brain disease (21974)
8:30 AM
How do you feel? Neuroimaging Correlates of Cognitive Affective Bias in Healthy Humans (21975)
8:30 AM
The Effect of a Novel Poly-Arginine Peptide on α-Synuclein Pathology Implicated in Parkinson's Disease (21980)
8:30 AM
Completion of Massive Open Online Course Improved Global Distribution of Knowledge about Traumatic Brain Injury (21981)
8:30 AM
Exploring the relationship between Alzheimer's disease, oral health, and the oral microbiome: A narrative review (21984)
8:30 AM
Investigating a novel dopaminergic projection from Ventral Tegmental Area to Ventral Hippocampus in associative learning (21992)
8:30 AM
Expression profile of the clustered protocadherins in the mouse hippocampus and their role in engram formation and memory processes (21993)
8:30 AM
Small molecule TrkB agonists enhance the generation of striatal neurons. (21996)
8:30 AM
SARS-CoV-2 impact on oligodendrocyte lineage cells (22000)
8:30 AM
Positive experience shifts the fear circuit away from the basolateral amygdala (22001)
8:30 AM
Characterising α-Synuclein Related Gut Microbial Dysfunction in a Transgenic Synucleinopathy Model of Parkinson’s disease (22003)
8:30 AM
Investigating rTMS Interventions in an Adolescent Model of Mood Disorders (22004)
8:30 AM
Actin dysregulation in transgenic FUS animal models and its novel isoform EC-FUS (22009)
8:30 AM
Three-dimensional characterisation of pelvic ganglia development in the human embryo (22012)
8:30 AM
Investigating the effect of the oxytocin-receptor agonist LIT-001 on the expression and extinction of conditioned avoidance in female rats (22013)
8:30 AM
Associations of Plasma Lipid Correlation Network Profiles with Global Cognition in Cognitively Normal Older Adults (22014)
8:30 AM
Direct In Vitro Reprogramming of Reactive Astrocytes Using NeuroD1 Promoting Cre-FLEX AAV-5 (22017)
8:30 AM
Opioid and Dopamine interaction in the amygdala-striatal transition zone regulate fear learning. (22020)
8:30 AM
The vasopressin receptor antagonist SRX246 alters expression and extinction of conditioned avoidance in rats. (22027)
8:30 AM
Investigating the Relationship Between Neuroinflammation and Synaptic Loss (22031)
8:30 AM
Clearing the fog: The potential of plasmalogens in mitigating chemotherapy-induced cognitive impairment. (22035)
8:30 AM
Machine learning‑based segmentation and classification of axons following optic nerve injury (22036)
8:30 AM
Impact of chronic repetitive transcranial magnetic stimulation on the retinocollicular pathway in ephrin-A2 knockout mice: a retrograde tracing approach (22038)
8:30 AM
Resilience and coping as defenders or drivers of symptom severity following mild traumatic brain injury. (22045)
8:30 AM
Dopamine and Acetylcholine release dynamics in the pDMS during the acquisition and updating of goal-directed behaviour (22047)
8:30 AM
Chronic fatigue syndrome is accompanied by lower persistent inward current activity of the tibialis anterior muscle (22050)
8:30 AM
The tryptamine-derivatives, 5-methyltryptamine and 5-methoxytryptamine, increase cell viability in a Parkinsonian cell culture model. (22051)
8:30 AM
Uncovering novel interacting partners for the NLR family protein NLRX1 in Parkinson’s disease (22055)
8:30 AM
Temporal profile of the development of cellular hallmarks of Parkinson’s disease following repeated mild traumatic brain injury (22056)
8:30 AM
Exploring the Alteration of Firmicutes and Bacteroides in Preclinical Alzheimer’s Disease (22060)
8:30 AM
Lesions of the lateral hypothalamus reduce contextual fear renewal in rats (22062)
8:30 AM
Neurofeedback Intervention for Persistent Post-Concussion Symptoms: A Case Series on Functional Connectivity in the Salience Network (22063)
8:30 AM
The role of axon initial segment plasticity in sensorineural hearing loss. (22068)
8:30 AM
Animals in Research Committee (22192)
8:30 AM
Long-term, high-resolution telemetry monitoring of circadian rhythmicity of temperature and activity in socially housed mice. (21878)
8:30 AM
Characterising the onset and maturation of neocortical activity in marsupial joeys (21966)
8:30 AM
Quantitative electroencephalography reveals regional brain dysfunction in mild traumatic brain injury (22043)
8:30 AM
S-allyl Cysteine and Cannabidiol are Equally Effective as Metformin in Preserving Neurovascular Integrity, Retinal Structure, and Cognitive Function in db/db Type 2 Diabetic Mice (22071)
8:30 AM
The Sporadic ALS Australia Systems Genomics Consortium: SALSA-SGC (22200)
8:30 AM
THE NEURAL CELL ADHESION MOLECULE 2 (NCAM2) PROMOTES SYNAPTOGENESIS THROUGH INCREASING INSULIN AND INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR SIGNALING (22202)
8:30 AM
Resistance training and cognition in adults with and without cognitive decline: an umbrella review (22203)
8:30 AM
Investigating what drives liquid-liquid phase separation in the ALS/MND-associated protein SFPQ (22205)
8:30 AM
Impaired locus coeruleus function in Alzheimer’s disease (22206)
8:30 AM
Assessing Firmicutes and Bacteroidetes Distributions in relation to Age, Gender, and APOE-ε4 allele Status in an Aging Australian Cohort (22210)
8:30 AM
Blood biomarkers for adult and childhood dementia (22211)
8:30 AM
Persisting symptoms, quality of life and return to work following mTBI in an Australian community-based cohort: results from the Concussion Recovery Study (CREST) (22213)
8:30 AM
Morphometric assessment of a koala brain using MR mapping methods (22214)
8:30 AM
Mental health, personality and quality of life factors affecting mTBI recovery in an Australian cohort. (22215)
8:30 AM
‘Reaching for Robotics’ : A mixed methods study of clinician perspectives on robot-assisted lower limb rehabilitation in Western Australia (22216)
8:30 AM
Repetitive Magnetic Stimulation Increases Intracellular Ca2+ Levels in Cultured Primary Oligodendrocytes (22217)
8:30 AM
Investigating the influence of ABCA7 polymorphism on the lipidome in the Busselton Healthy Ageing Study (BHAS) (22218)
8:30 AM
The Interplay Between Gut Microbiota, Inflammation, and Neurodevelopmental Disorders: A Focus on Autism Spectrum Disorder (22220)
8:30 AM
Alteration of Brain White Matter Tracts and Plasma Free Fatty Acid Concentrations following Mild Traumatic Brain Injury (22223)
8:30 AM
Prognostic Biomarkers for Childhood Dementia (22224)
8:30 AM
Biological Resilience in Stress Environments: The impact of Mild Traumatic Brain Injuries on Saliva Biomarkers (22225)
8:30 AM
Unlocking the potential for single-cell RNA sequencing and spatial analysis at scale with massively parallelized barcoding (22227)
8:30 AM
Hippocampal function is altered in a model of chronic neuropathic pain (22228)
8:30 AM
Analysis of gender and institutional representation of invited speakers at the ANS annual meeting (22234)
8:30 AM
Proteomic Profiling of the Ovine Brain: Insights for Translational Neuroscience Research (22242)
8:30 AM
“Rock on technology”: Perspectives on robot-assisted lower limb and gait neurorehabilitation from people with neurological conditions (22208)
8:30 AM